8-KOther Events

BRISTOL MYERS SQUIBB CO 8-K Report (Jul 30, 2004)

Filed July 30, 2004For Securities:BMYCELG-RIBMYMP

Summary

Bristol-Myers Squibb Company (BMY) has announced an agreement to settle a significant securities class action lawsuit. The lawsuit, titled _in re BMS Securities Litigation_, was filed in the U.S. District Court for the Southern District of New York and named the company along with several current and former officers as defendants. The litigation stemmed from various issues, including allegations related to wholesaler inventory and other accounting practices. Additionally, the lawsuit touched upon the company's investment in and relationship with ImClone Systems Inc., particularly concerning ImClone's product ERBITUX. This settlement marks a crucial step in resolving a prolonged period of legal uncertainty for the company.

Key Highlights

  • 1BMY has reached an agreement to settle a securities class action lawsuit.
  • 2The lawsuit, _in re BMS Securities Litigation_, was pending in the U.S. District Court in the Southern District of New York.
  • 3The lawsuit involved allegations concerning wholesaler inventory and other accounting matters.
  • 4The company's investment in and relationship with ImClone Systems Inc. and its product ERBITUX were also central to the litigation.
  • 5The settlement aims to resolve significant legal disputes for Bristol-Myers Squibb.
  • 6The announcement was made via a press release dated July 30, 2004.

Frequently Asked Questions

The main purpose of this 8-K filing is to announce that Bristol-Myers Squibb Company has reached an agreement to settle a securities class action lawsuit.

The lawsuit addressed issues related to wholesaler inventory and other accounting matters, as well as the company's investment in and relationship with ImClone Systems Inc. and its product ERBITUX.

The lawsuit involved Bristol-Myers Squibb Company and a number of its current and former officers as defendants, and was filed in the U.S. District Court for the Southern District of New York.

This settlement is significant for investors as it resolves a major legal uncertainty that has been ongoing, potentially impacting the company's financial performance and stock value. It suggests a move towards resolving past controversies related to accounting and business relationships.